ADGI insider filings
Adagio Therapeutics, Inc. — 36 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-09-01. Screen ADGI transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ADGI between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Adagio Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-09-01 | 4 | Hering David — Chief Executive Officer, Director | Purchase (P): 8,000 @ $4.52 | EDGAR |
| 2022-08-19 | 4 | Elia Marc — Director M28 Capital Management LP | Purchase (P): 1,000,000 @ $4.04 · Purchase (P): 1,265,549 @ $4.31 · Purchase (P): 584,451 @ $4.62 | EDGAR |
| 2022-07-06 | 4 | Hering David — Chief Executive Officer, Director | Grant/award (A): 2,000,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Berry Tamsin — Director | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Miller Redonda — Director | Grant/award (A): 44,178 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Heyman Tomas J. — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Elia Marc — Director M28 Capital Management LP | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Mayer Howard — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | MEANWELL CLIVE — Director, 10% owner | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | WYZGA MICHAEL S — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | MCGUIRE TERRANCE — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2022-04-01 | 4 | Adimab, LLC — 10% owner | Other (J): 1,158,089 | EDGAR |
| 2022-03-30 | 4 | Royan Ajay — Director, 10% owner | Holdings only — no transactions reported | EDGAR |
| 2022-03-30 | 4 | MITHRIL II LP — 10% owner Mithril II GP LP — 10% owner Mithril II UGP LLC — 10% owner THIEL PETER — 10% owner | Holdings only — no transactions reported | EDGAR |
| 2022-03-30 | 4 | MCGUIRE TERRANCE — Director | Holdings only — no transactions reported | EDGAR |
| 2022-02-01 | 4 | Hershberger Elham — Chief Development Officer | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2022-02-01 | 4 | Hering David — Chief Operating Officer | Grant/award (A): 475,000 (derivative) @ $0 | EDGAR |
| 2022-02-01 | 4 | Dabora Rebecca — Chief Tech and Manuf Officer | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2022-02-01 | 4 | Connolly Lynn — Chief Medical Officer | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2022-02-01 | 4 | Andersen Jill — Chief Legal Officer, Secretary | Grant/award (A): 575,000 (derivative) @ $0 | EDGAR |
| 2022-02-01 | 4 | Gerngross Tillman U. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2022-02-01 | 4 | Henderson Jane — Chief Financial Officer | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2021-11-23 | 4 | Miller Redonda — Director | Grant/award (A): 62,605 (derivative) @ $0 | EDGAR |
| 2021-11-23 | 4 | MARRAM ELLEN R — Director | Grant/award (A): 62,605 (derivative) @ $0 | EDGAR |
| 2021-11-02 | 4 | Andersen Jill — Chief Legal Officer, Secretary | Grant/award (A): 514,863 (derivative) @ $0 | EDGAR |
| 2021-08-12 | 4 | Royan Ajay — Director, 10% owner | Conversion (C): 9,244,580 · Purchase (P): 1,997,000 @ $17 · Conversion (C): 1,250,000 (derivative) @ $0 · Conversion (C): 176,304 (derivative) @ $0 · Conversion (C): 422,612 (derivative) @ $0 | EDGAR |
| 2021-08-12 | 4 | Gerngross Tillman U. — Chief Executive Officer, Director, 10% owner | Conversion (C): 25,860,700 · Conversion (C): 5,000,000 (derivative) @ $0 · Conversion (C): 44,076 (derivative) @ $0 · Conversion (C): 128,064 (derivative) @ $0 | EDGAR |
| 2021-08-12 | 4 | Adimab, LLC — 10% owner | Conversion (C): 25,860,700 · Conversion (C): 5,000,000 (derivative) @ $0 · Conversion (C): 44,076 (derivative) @ $0 · Conversion (C): 128,064 (derivative) @ $0 | EDGAR |
| 2021-08-12 | 4 | Redmile Group, LLC — 10% owner Green Jeremy — 10% owner | Conversion (C): 1,920,960 · Purchase (P): 1,470,000 @ $17 · Conversion (C): 1,920,960 (derivative) @ $0 | EDGAR |
| 2021-08-12 | 4 | MITHRIL II LP — 10% owner Mithril II GP LP — 10% owner Mithril II UGP LLC — 10% owner THIEL PETER — 10% owner | Conversion (C): 9,244,580 · Purchase (P): 1,997,000 @ $17 · Conversion (C): 1,250,000 (derivative) @ $0 · Conversion (C): 176,304 (derivative) @ $0 · Conversion (C): 422,612 (derivative) @ $0 | EDGAR |
| 2021-08-12 | 4 | MCGUIRE TERRANCE — Director | Conversion (C): 2,852,425 · Purchase (P): 267,769 @ $17 · Conversion (C): 55,595 · Purchase (P): 5,219 @ $17 · Conversion (C): 19,540 · Purchase (P): 1,834 @ $17 · +22 more | EDGAR |
| 2021-08-09 | 4 | Royan Ajay — Director, 10% owner | Grant/award (A): 35,593 (derivative) @ $0 | EDGAR |
| 2021-08-09 | 4 | Russo Rene — Director | Grant/award (A): 35,593 (derivative) @ $0 | EDGAR |
| 2021-08-09 | 4 | Mayer Howard — Director | Grant/award (A): 35,593 (derivative) @ $0 | EDGAR |
| 2021-08-09 | 4 | WYZGA MICHAEL S — Director | Grant/award (A): 71,186 (derivative) @ $0 | EDGAR |
| 2021-08-09 | 4 | MCGUIRE TERRANCE — Director | Grant/award (A): 35,593 (derivative) @ $0 | EDGAR |
Recent 8-K events — Adagio Therapeutics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-24 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-07-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-19 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-09 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-05 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ADGI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs